Literature DB >> 3969880

Vascular hemodynamic impedance in congestive heart failure.

S M Finkelstein, J N Cohn, V R Collins, P F Carlyle, W J Shelley.   

Abstract

The objective of this study was to determine whether pulse-contour analysis could provide a measure of the differences in peripheral vascular state between patients with congestive heart failure (CHF) and healthy persons. Vascular hemodynamic impedance parameters were determined from brachial artery pressure waveforms recorded in 14 patients with CHF, aged 20 to 55 years (mean 36 +/- 12) and in 7 healthy control subjects, aged 22 to 55 years (mean 33 +/- 12). Cardiac output, heart sounds and electrocardiogram were also monitored. Cardiac output was 32% lower (p less than 0.01) and heart rate was 43% higher (p less than 0.001) in the CHF group than in the control group. The mean arterial pressure did not differ between groups. Systemic vascular resistance was 47% higher (p less than 0.05) and distal vascular compliance 73% lower (p less than 0.001) in the CHF group than in control group. Proximal vascular compliance was unchanged. These studies suggest that distal compliance assessed from pulse-contour analysis is a more sensitive and specific index than systemic vascular resistance to the vascular changes in CHF.

Entities:  

Mesh:

Year:  1985        PMID: 3969880     DOI: 10.1016/0002-9149(85)90387-x

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  3 in total

1.  Computer simulation of the mechanically-assisted failing canine circulation.

Authors:  O Barnea; T W Moore; D Jaron
Journal:  Ann Biomed Eng       Date:  1990       Impact factor: 3.934

Review 2.  Physiological rationale for co-treatment with diuretics in heart failure.

Authors:  J N Cohn
Journal:  Br Heart J       Date:  1994-08

3.  Computational Parametric Studies Investigating the Global Hemodynamic Effects of Applied Apical Torsion for Cardiac Assist.

Authors:  Elaine Soohoo; Lewis K Waldman; Dennis R Trumble
Journal:  Ann Biomed Eng       Date:  2017-03-02       Impact factor: 3.934

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.